News

Stress induced by COVID-19 is driving opioid addiction risks. An expert weighs in on addressing one matter to resolve another.

Patients treated with ustekinumab had significantly more prior biologic use than patients treated with vedolizumab.

Positive detection rate for FH through next-generation sequencing was 27.0%, compared to 8.4% using 24-variant array based test.

The US is closing in on the goal of having 70% of adults vaccinated by July 4.

Secukinumab is the only fully human biologic that directly inhibits IL-17A.

All patients with severe disease had abnormal ECG readings.

New research sheds light on the relationship between sleep timing and the risk of developing major depressive disorder (MDD).

The oral combination therapy can also be used as acute treatment for manic or mixed episodes.

Data show low BMI, male gender, and older age in patients associated with higher overall mortality.

As the world begins to open its borders, international travelers need to remain diligent of limitations and risks.

Derek Jones, VP Enterprise Strategy, Americas at Deputy, gives tips on staffing strategies.

W. Schuyler Jones, MD, and Manesh Patel, MD discuss the influences the aspirin-dosing cardiology trial may have on future studies.

The US has reached the 50% mark for vaccinations for adults.

Jordana Hoppe, MD, discusses the burden of cystic fibrosis on infants and children.

The treatment is also being studied for safety and efficacy in patients with Crohn’s disease.

The company expects to file for FDA authorization for the 12-17 year old population in June.

Multiple studies have found a decrease in CDI rates during the COVID-19 pandemic in comparison to previous years.

The EMDAC voted 10-7 to support the benefit-risks of teplizumab for delaying clinical type 1 diabetes.

Specialist intervention is likely not necessary for low-risk patients; and so, non-liver specialists can be reassured of G/P’s safety profile.

Weekly number of opioid-related deaths increased 135% over study period.

A longer duration of medication use during pregnancy was linked to decreases in odds of overdose and preterm birth.

Esophageal cancer has a low survival rate largely due to advanced stage diagnosis.

Nearly two-thirds of patients had improved or resolved EIM after ustekinumab treatment.

A large proportion of IBS-C patients did not seek health care during the COVID-19 pandemic despite symptoms.

There was a notable association between the comorbid population and congestive heart failure exacerbations.

Arena Pharmaceuticals expects to move forward with later phase clinical trials testing etrasimod.

Patients with opioid-induced constipation had more frequent, painful constipation symptoms, compared to those with chronic idiopathic constipation.

Direct optical endoscopy are often underutilized in screenings for EAC.